Intended for UK Healthcare Professionals only. Adverse Event Reporting information can be found at the bottom of the page.
This website contains promotional information

Our medicines

With a long standing history of providing treatments throughout Europe, MEDICE now supplies a range of medicines to patients in the UK.

MEDICE UK was established in 2022 and we support UK healthcare professionals with treatments for various therapy areas:

ADHD (attention deficit hyperactivity disorder)

Explore the treatments we have available in the UK, in ADHD:

Medikinet® XL

(methylphenidate hydrochloride)

Medikinet® XL is a prescription-only medicine. For further information on this product, please see the SPC.

Prescribing Information can be found here

Learn more

Medikinet® tablets

(methylphenidate hydrochloride)

Medikinet® tablets are a prescription-only medicine. For further information on this product, please see the SPC.

Prescribing Information can be found here

Learn more

Amfexa®

(dexamfetamine sulfate)

Amfexa® is a prescription-only medicine. For further information on this product, please see the SPC.

Prescribing Information can be found here

Learn more

Nephrology

Explore the treatments we have available in the UK, in Nephrology:

Vafseo®

(vadadustat)

Vafseo® is a prescription-only medicine. For further information on this product, please see the SPC.

Prescribing Information can be found here

Learn more

Nephrotrans®

(sodium hydrogen carbonate)

Nephrotrans® is a prescription-only medicine. For further information on this product, please see the SPC.

Prescribing Information can be found here

Learn more

Urology

Explore the treatment we have available in the UK, in Urology:

Velariq®

(oxybutynin hydrochloride)

Velariq® is a prescription-only medicine. For further information on this product, please see the SPC

Prescribing Information can be found here.

Learn more

Contact us

If you would like to find out more about our treatments or therapy area expertise, please contact us

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.

Date of Preparation: August 2024 UK-COR-2024-1641-v1

Adverse event reporting
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should be reported to MEDICE UK, Medical Information Tel: 0204 582 2845, medicalinformation@medice.co.uk